Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Opioid Tolerance as Revealed by Functional MRI
2007-004250-81Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of remifentanil in opioid use disorder (OUD), sponsored by Helsinki University Hospital. Primary endpoint: Functional MRI measures of acute opioid tolerance. Started Aug 2007; status: completed.
02
Drugs
remifentanil
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on 2007-004250-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004250-81.